Form 4: Hoyoung Huh Acquires 26,764 Shares of Pliant Therapeutics via Stock Option

Director Hoyoung Huh acquired 26,764 shares of Pliant Therapeutics (PLRX) through a stock option grant on June 13, 2024.

Summary

• Hoyoung Huh, a director of Pliant Therapeutics, acquired 26,764 shares of common stock through a stock option on June 13, 2024.
• The exercise price of the option is $13.06 per share.
• The options vest quarterly, with 25% vesting on the first day of each calendar quarter for three quarters following the grant date.
• The remaining 25% vests on the earlier of the one-year anniversary of the grant date (June 13, 2024) or the next annual meeting of stockholders, contingent upon continued service as a director.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock option grants, which is neutral in sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their holdings in the company's stock.

Stakeholder Impact

• The transaction increases the director's stake in the company, potentially aligning their interests more closely with those of shareholders.

Key Dates